These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21715326)

  • 1. Phage display of tissue inhibitor of metalloproteinases-2 (TIMP-2): identification of selective inhibitors of collagenase-1 (metalloproteinase 1 (MMP-1)).
    Bahudhanapati H; Zhang Y; Sidhu SS; Brew K
    J Biol Chem; 2011 Sep; 286(36):31761-70. PubMed ID: 21715326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
    Hamze AB; Wei S; Bahudhanapati H; Kota S; Acharya KR; Brew K
    Protein Sci; 2007 Sep; 16(9):1905-13. PubMed ID: 17660250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases.
    Huang W; Meng Q; Suzuki K; Nagase H; Brew K
    J Biol Chem; 1997 Aug; 272(35):22086-91. PubMed ID: 9268350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
    Nagase H; Brew K
    Biochem Soc Symp; 2003; (70):201-12. PubMed ID: 14587293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
    Troeberg L; Tanaka M; Wait R; Shi YE; Brew K; Nagase H
    Biochemistry; 2002 Dec; 41(50):15025-35. PubMed ID: 12475252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminus of collagenase MMP-8 determines superactivity and inhibition: a relation of structure and function analyzed by biomolecular interaction analysis.
    Farr M; Pieper M; Calvete J; Tschesche H
    Biochemistry; 1999 Jun; 38(22):7332-8. PubMed ID: 10353844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
    Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R
    J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
    Raeeszadeh-Sarmazdeh M; Greene KA; Sankaran B; Downey GP; Radisky DC; Radisky ES
    J Biol Chem; 2019 Jun; 294(24):9476-9488. PubMed ID: 31040180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli. Comparison of wild type and amino-terminal alanine appended variant with implications for the mechanism of TIMP functions.
    Wingfield PT; Sax JK; Stahl SJ; Kaufman J; Palmer I; Chung V; Corcoran ML; Kleiner DE; Stetler-Stevenson WG
    J Biol Chem; 1999 Jul; 274(30):21362-8. PubMed ID: 10409697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1.
    Iyer S; Wei S; Brew K; Acharya KR
    J Biol Chem; 2007 Jan; 282(1):364-71. PubMed ID: 17050530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
    Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
    Itoh Y; Ito A; Iwata K; Tanzawa K; Mori Y; Nagase H
    J Biol Chem; 1998 Sep; 273(38):24360-7. PubMed ID: 9733724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2).
    Xu X; Mikhailova M; Chen Z; Pal S; Robichaud TK; Lafer EM; Baber S; Steffensen B
    Matrix Biol; 2011 Sep; 30(7-8):404-12. PubMed ID: 21839835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
    Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
    Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
    Lee MH; Rapti M; Knaüper V; Murphy G
    J Biol Chem; 2004 Apr; 279(17):17562-9. PubMed ID: 14734567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.
    Remacle AG; Shiryaev SA; Radichev IA; Rozanov DV; Stec B; Strongin AY
    J Biol Chem; 2011 Jun; 286(23):21002-12. PubMed ID: 21518756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of eCG treatment on gene expression of selected matrix metalloproteinases (MMP-2, MMP-7, MMP-9, MMP-10, and MMP-13) and the tissue inhibitors of metalloproteinases (TIMP-2 and TIMP-3) in the chicken ovary.
    Wolak D; Sechman A; Hrabia A
    Anim Reprod Sci; 2021 Jan; 224():106666. PubMed ID: 33260067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue.
    Kubota T; Nomura T; Takahashi T; Hara K
    Arch Oral Biol; 1996 Mar; 41(3):253-62. PubMed ID: 8735011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix.
    Davidson B; Goldberg I; Liokumovich P; Kopolovic J; Gotlieb WH; Lerner-Geva L; Reder I; Ben-Baruch G; Reich R
    Int J Gynecol Pathol; 1998 Oct; 17(4):295-301. PubMed ID: 9785129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
    Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
    Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.